Abbott Research B.V.
Records under this name other than patents Abbott Research B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Abbott Research B.V.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,688,749 | Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect Formerly held Lapsed on the fee record Ended Jun 27, 2021 · USPTO record | Lapsed on the fee record | Ended Jun 27, 2021 | USPTO record |
| US 8,435,523 | Antibodies against nerve growth factor (NGF) with enhanced in vivo stability Formerly held Lapsed on the fee record Ended May 7, 2021 · USPTO record | Lapsed on the fee record | Ended May 7, 2021 | USPTO record |
| US 9,447,181 | Antibodies against nerve growth factor (NGF) with enhanced in vivo stability Formerly held Lapsed on the fee record Ended Sep 20, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 20, 2020 | USPTO record |
| US 8,257,710 | Method for the treatment of pain with humanized anti-nerve growth factor antibodies Formerly held Lapsed on the fee record Ended Sep 4, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 4, 2020 | USPTO record |
| US 8,246,956 | Humanized anti-nerve growth factor antibodies Formerly held Lapsed on the fee record Ended Aug 21, 2020 · USPTO record | Lapsed on the fee record | Ended Aug 21, 2020 | USPTO record |
| US 8,877,491 | Polynucleotides encoding humanized anti-NGF antibodies Formerly held Lapsed on the fee record Ended Nov 4, 2018 · USPTO record | Lapsed on the fee record | Ended Nov 4, 2018 | USPTO record |